Sissy Goff and David Thomas, licensed professional counselors and New York Times bestselling authors of “Capable: How to Teach Your Kids the Strengths, Skills and Strategies to Build Reslience,” join TODAY to discuss ways that moms and dads can give themselves grace and enjoy the overwhelming holiday season. Sissy Goff and David Thomas, licensed professional counselors…
There’s a new alert on those popular GLP-1 weight loss drugs. The FDA is now mandating a warning label that the drugs may cause sudden blindness. NBC News’ Stephanie Gosk reports. There’s a new alert on those popular GLP-1 weight loss drugs. The FDA is now mandating a warning label that the drugs may cause sudden…
The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness. The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness.
An experimental drug that held great promise in driving down a dangerous form of cholesterol didn’t show any measurable impact on heart attack or stroke in a clinical trial. An experimental drug that held great promise in driving down a dangerous form of cholesterol didn’t show any measurable impact on heart attack or stroke in a…
Sissy Goff and David Thomas, licensed professional counselors and New York Times bestselling authors of “Capable: How to Teach Your Kids the Strengths, Skills and Strategies to Build Reslience,” join TODAY to discuss ways that moms and dads can give themselves grace and enjoy the overwhelming holiday season. Sissy Goff and David Thomas, licensed professional counselors…
There’s a new alert on those popular GLP-1 weight loss drugs. The FDA is now mandating a warning label that the drugs may cause sudden blindness. NBC News’ Stephanie Gosk reports. There’s a new alert on those popular GLP-1 weight loss drugs. The FDA is now mandating a warning label that the drugs may cause sudden…
The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness. The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness.
An experimental drug that held great promise in driving down a dangerous form of cholesterol didn’t show any measurable impact on heart attack or stroke in a clinical trial. An experimental drug that held great promise in driving down a dangerous form of cholesterol didn’t show any measurable impact on heart attack or stroke in a…
From copper peptides to PDRN made from salmon DNA, social media is filled with advice and viral skin care ingredients, but which products actually deserve a spot in your routine? Board-certified dermatologist Marnie Nussbaum joins TODAY to break it all down. From copper peptides to PDRN made from salmon DNA, social media is filled with advice…
CVS Health says it is splitting in two, putting its retail pharmacy in one unit and its insurance side, which oversees Aetna and Caremark, will be separate. The CEO says the idea is to help customer engagement, affordability and care coordination. CVS Health says it is splitting in two, putting its retail pharmacy in one unit…
After her insurer denied a milder chemotherapy her oncologist prescribed, breast cancer patient Elizabeth Nicholas emailed the CEO — and got it approved 14 hours later. NBC News’ Kate Snow reports. After her insurer denied a milder chemotherapy her oncologist prescribed, breast cancer patient Elizabeth Nicholas emailed the CEO — and got it approved 14 hours…
The infant’s death followed a measles-associated death reported Wednesday in Pennsylvania and another Monday in New York. The infant’s death followed a measles-associated death reported Wednesday in Pennsylvania and another Monday in New York.
A promising new study reveals many babies diagnosed with peanut allergies may no longer be allergic. NBC News medical contributor Dr. Natalie Azar joins the 3rd Hour of TODAY to share more on these findings and what parents of children with a peanut allergy should know. A promising new study reveals many babies diagnosed with peanut…
It’s that time of year again: open enrollment season. With rates rising and changes affecting many plans, you might want to take a closer look at your plan before you renew. NBC’s chief business correspondent Christine Romans joins the 3rd Hour of TODAY to share tips to ensure you pick the best plan for your…
